Please login to the form below

Not currently logged in
Email:
Password:

European pharma industry calls for 'robust' HTA framework

Healthcare bodies including pharma association EFPIA seek a more transparent framework for health technology assessment
European healthcare organisations have called for a 'robust and transparent framework' for health technology assessment (HTA) to allow the industry to manage its resources more effectively.

This will encourage the development of new and innovative technologies for the benefit of patients and society, they say.

The call is featured in a joint paper produced by organisations including the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Generic Medicines Association (EGA) and the European Association for Bioindustries (EuropaBio).

Their jointly developed paper The value of industry involvement in HTA was presented at the European HTA network EUnetHTA's conference in Gdansk.

The paper say industry is a 'valuable partner' in the HTA process, but needs greater support from the EUnetHTA.

The organisations also describe the stages of the HTA process where industry could add value and citing early industry involvement with the UK National Institute for Health and Clinical Excellence 's (NICE) evaluation pathway for medical devices and diagnostics as an example of successful collaboration.

Specific technology assessments and their constituent phases were also recognised as an area for positive industry involvement.

This included the data gathering and pre-submission discussion stage, when industry organisations can clarify or methodological guidance. The assessment of evidence and production of recommendation stage was another area for further involvement. This could provide an opportunity for manufacturers to discuss their HTA submissions with regulatory agencies to enhance the quality of specific assessments by giving further opportunities to discuss study designs and models.

In a joint statement, all involved organisations said: “The healthcare industry looks forward to continue working with the EUnetHTA Joint Action to ensure that the European collaboration on HTA is a success. This includes making sure that industry is fully involved in the policy discussions within that forum as well as in the future pilots that will be taken on going forward.”

12th December 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics